Autoimmune diseases are a group of conditions in which the immune system mistakenly attacks healthy cells and tissues in the body. While the exact causes of autoimmune diseases are not fully understood, research has identified a number of genetic factors that are associated with an increased risk of developing these conditions.
Genetic testing for autoimmune diseases is an area of ongoing research and discovery. While there are no genetic tests currently available for the diagnosis of most autoimmune diseases, research has identified specific genes that are associated with an increased risk of developing conditions such as rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes.
Variations in genes such as HLA, CTLA-4, PTPN22, IL-23R, and TNF-alpha have been linked to an increased risk of developing autoimmune diseases. However, it’s important to note that having these genetic variants does not necessarily mean that an individual will develop the associated autoimmune disease. Other genetic and environmental factors also play a role in the development of autoimmune diseases.
The HLA (human leukocyte antigen) genes are a group of genes that are involved in the immune system’s recognition of the body and parts that are foreign and harmful. Variations in these genes are associated with an increased risk of developing several autoimmune diseases, including type 1 diabetes, rheumatoid arthritis, and multiple sclerosis. Similarly, variations in the CTLA-4 gene have been linked to an increased risk of developing autoimmune thyroid disease, type 1 diabetes, and lupus. Variations in the PTPN22 gene have been associated with an increased risk of developing rheumatoid arthritis, lupus, and type 1 diabetes. Variations in the IL-23R gene have been linked to an increased risk of developing psoriasis, Crohn’s disease, and ulcerative colitis. Finally, variations in the TNF-alpha gene have been associated with an increased risk of developing rheumatoid arthritis, psoriasis, and ankylosing spondylitis.
While genetic testing for autoimmune diseases is currently limited to research settings, the identification of these genes provides valuable insight into the genetic basis of these conditions. As our understanding of the genetics of autoimmune diseases continues to evolve, it’s possible that genetic testing may play a greater role in the diagnosis and management of these conditions in the future. For now, the diagnosis of autoimmune diseases is primarily based on clinical symptoms and laboratory tests.
- Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med. 2011 Apr 28;364(17):1614-25. doi: 10.1056/NEJMra0911582. PMID: 21506741.
- Marson A, Housley WJ, Hafler DA. Genetic basis of autoimmunity. J Clin Invest. 2015 Feb;125(2):223-9. doi: 10.1172/JCI75094. Epub 2015 Jan 20. PMID: 25607908; PMCID: PMC4319434.
- Albert LJ, Inshaw JRJ, Kariuki SN, et al. Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage. Curr Opin Immunol. 2019 Dec;61:1-8. doi: 10.1016/j.coi.2019.06.003. Epub 2019 Jul 10. PMID: 31299585; PMCID: PMC6855012.
- Piotrowski P, Lianeri M, Wudarski M, et al. HLA-DQB1 gene polymorphisms and their relevance to autoimmune hepatitis and other autoimmune diseases. Autoimmunity. 2014 Aug;47(5):318-25. doi: 10.3109/08916934.2014.902938. Epub 2014 Apr 1. PMID: 24690352.
- Shi Y, Xie F, Chen X, et al. CTLA-4 polymorphism confers genetic susceptibility to type 1 diabetes: evidence from 18,000 patients meta-analysis. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12765-71. PMID: 26722435; PMCID: PMC4688116.
- Slavich M, Arosio B, Crosti F, et al. Cytokine gene polymorphisms and susceptibility to inflammatory bowel disease. Curr Pharm Des. 2010;16(6):652-60. doi: 10.2174/138161210790883613. PMID: 20030658.
- Rothe H, Hosseini SM, Schumacher N, et al. TNF-α, a multifunctional proinflammatory cytokine in psoriasis. J Clin Med. 2021 May 3;10(9):1855. doi: 10.3390/jcm10091855. PMID: 34063775; PMCID: PMC8401033.